Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan

Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan

Ember offers Japanese market pharmaceutical transportation solution integrating temperature control, visualization of transportation status and traceabilityLOS ANGELES, July 29, 2026 /PRNewswire/ -- Ember LifeSciences, Inc. ("Ember"), an award-winning provider of advanced pharmaceutical cold chain solutions, has entered into…
/C O R R E C T I O N — InstaMed® Pharmaceuticals/

/C O R R E C T I O N — InstaMed® Pharmaceuticals/

In the news release, Biotech Innovator InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of Worldwide Launch of Non-Injectable Peptide Platform, issued 27-Jul-2026 by InstaMed® Pharmaceuticals over PR Newswire, we are advised by the company…